NAGE (Niagen Bioscience) E10: $-0.30 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NAGE Niagen Bioscience Inc NAGE
68 GF Score
Price $3.17
GF Value $4.94
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Niagen Bioscience E10?

Niagen Bioscience NAGE +3.76% 68 E10 is $-0.30 as of Jun. 2026. GuruFocus rates NAGE with a GF Score™ of 68/100 and a GF Value™ of $4.94 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Niagen Bioscience's adjusted earnings per share data for the three months ended in Jun. 2026 was $0.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.30 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Niagen Bioscience was 5.00% per year. The lowest was -15.70% per year. And the median was -6.55% per year.

As of today (2026-08-19), Niagen Bioscience's current stock price is $3.17. Niagen Bioscience's E10 for the quarter that ended in Jun. 2026 was $-0.30. Niagen Bioscience's Shiller PE Ratio of today is .


Niagen Bioscience  (NAS:NAGE) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Niagen Bioscience E10 Related Terms


Niagen Bioscience E10 Historical Data

* Premium members only.

The historical data trend for Niagen Bioscience's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Niagen Bioscience E10 Chart

Niagen Bioscience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.35 -0.35 0.00 -0.33 -0.30

Niagen Bioscience Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.32 -0.31 -0.30 -0.30 -0.30

NAGE vs LCTX, IFRX, VRXA: E10 Comparison

For the Biotechnology subindustry, Niagen Bioscience's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Niagen Bioscience Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Niagen Bioscience's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Niagen Bioscience's Shiller PE Ratio falls into.


NAGE
68GF Score
Niagen Bioscience Inc NAGE
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Niagen Bioscience E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Niagen Bioscience's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.01/333.9520*333.9520
=0.010

Current CPI (Jun. 2026) = 333.9520.

Niagen Bioscience Quarterly Data

per share eps CPI Adj_EPS
201609 -0.030 241.428 -0.041
201612 -0.060 241.432 -0.083
201703 -0.050 243.801 -0.068
201706 -0.070 244.955 -0.095
201709 0.040 246.819 0.054
201712 -0.170 246.524 -0.230
201803 -0.150 249.554 -0.201
201806 -0.150 251.989 -0.199
201809 -0.160 252.439 -0.212
201812 -0.150 251.233 -0.199
201903 -0.150 254.202 -0.197
201906 -0.140 256.143 -0.183
201909 -0.120 256.759 -0.156
201912 -0.150 256.974 -0.195
202003 -0.100 258.115 -0.129
202006 -0.060 257.797 -0.078
202009 -0.070 260.280 -0.090
202012 -0.100 260.474 -0.128
202103 -0.120 264.877 -0.151
202106 -0.080 271.696 -0.098
202109 -0.130 274.310 -0.158
202112 -0.080 278.802 -0.096
202203 -0.110 287.504 -0.128
202206 -0.090 296.311 -0.101
202209 -0.010 296.808 -0.011
202212 -0.020 296.797 -0.023
202303 -0.030 301.836 -0.033
202306 -0.030 305.109 -0.033
202309 -0.010 307.789 -0.011
202312 0.000 306.746 0.000
202403 -0.010 312.332 -0.011
202406 0.000 314.175 0.000
202409 0.020 315.301 0.021
202412 0.090 315.605 0.095
202503 0.060 319.799 0.063
202506 0.040 322.561 0.041
202509 0.050 324.800 0.051
202512 0.050 324.054 0.052
202603 0.070 330.213 0.071
202606 0.010 333.952 0.010

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.30 mean?
Niagen Bioscience (NAGE) has a E10 of $-0.30 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Niagen Bioscience and its competitors.
Is Niagen Bioscience's E10 too high?
Niagen Bioscience's current E10 is $-0.30. Overall, Niagen Bioscience has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Niagen Bioscience's E10 compare to LCTX and IFRX?
Niagen Bioscience's E10 of $-0.30 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Niagen Bioscience and its competitors. Niagen Bioscience's current E10 is $-0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Niagen Bioscience stock overvalued right now?
Based on GuruFocus' analysis, Niagen Bioscience (NAGE) is currently considered Possible Value Trap. The stock's GF Value™ is $4.94, compared to a current price of $3.17 — trading 35.8% below its estimated fair value. The current E10 is $-0.30. Niagen Bioscience's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Niagen Bioscience (NAGE), the current E10 is $-0.30 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Niagen Bioscience (NAGE) Overvalued in 2026?

Based on GuruFocus' analysis, Niagen Bioscience stock appears to be undervalued. The current stock price of $3.17 is trading 35.8% below its estimated GF Value™ of $4.94. GuruFocus considers Niagen Bioscience to be Possible Value Trap.

Key valuation signals for NAGE:

  • E10: $-0.30
  • GF Value™: $4.94 vs. price of $3.17 (35.8% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the NAGE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Niagen Bioscience Business Description

Other Exchanges OCD1:Germany
Address 10900 Wilshire Boulevard, Suite 600, Los Angeles, CA, USA, 90024
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
68GF Score

Get the complete analysis for NAGE

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.17
Price
$4.94
GF Value